Business Description
Dr Lalchandani Labs Ltd
ISIN : INE871Z01013
Share Class Description:
BOM:541299: Ordinary SharesCompare
Compare
Traded in other countries / regions
541299.India IPO Date
2018-05-09Description
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.71 | |||||
| Debt-to-EBITDA | 12.64 | |||||
| Interest Coverage | 0.15 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.29 | |||||
| Beneish M-Score | -2.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6 | |||||
| 3-Year FCF Growth Rate | 24.6 | |||||
| 3-Year Book Growth Rate | 1.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.81 | |||||
| 9-Day RSI | 61.44 | |||||
| 14-Day RSI | 57.6 | |||||
| 6-1 Month Momentum % | -33.03 | |||||
| 12-1 Month Momentum % | -14.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.13 | |||||
| Quick Ratio | 1.85 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 300.12 | |||||
| Days Sales Outstanding | 338.79 | |||||
| Days Payable | 245.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.41 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.77 | |||||
| Operating Margin % | 1.4 | |||||
| Net Margin % | -12.37 | |||||
| FCF Margin % | -5.54 | |||||
| ROE % | -7.46 | |||||
| ROA % | -3.79 | |||||
| ROIC % | 0.57 | |||||
| ROC (Joel Greenblatt) % | -1.59 | |||||
| ROCE % | -1.27 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 21.95 | |||||
| PS Ratio | 1.74 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| Price-to-Operating-Cash-Flow | 533.7 | |||||
| EV-to-EBIT | -77.1 | |||||
| EV-to-EBITDA | 26.08 | |||||
| EV-to-Revenue | 2.38 | |||||
| EV-to-FCF | -42.56 | |||||
| Price-to-Projected-FCF | 10.71 | |||||
| Price-to-Net-Current-Asset-Value | 3.69 | |||||
| Earnings Yield (Greenblatt) % | -1.3 | |||||
| FCF Yield % | -3.33 | |||||
| Forward Rate of Return (Yacktman) % | 14.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dr Lalchandani Labs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 54.824 | ||
| EPS (TTM) (₹) | -1.57 | ||
| Beta | -1.59 | ||
| Volatility % | 81.74 | ||
| 14-Day RSI | 57.6 | ||
| 14-Day ATR (₹) | 0.356864 | ||
| 20-Day SMA (₹) | 20.7155 | ||
| 12-1 Month Momentum % | -14.79 | ||
| 52-Week Range (₹) | 15.68 - 32.7 | ||
| Shares Outstanding (Mil) | 4.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr Lalchandani Labs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr Lalchandani Labs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dr Lalchandani Labs Ltd Frequently Asked Questions
What is Dr Lalchandani Labs Ltd(BOM:541299)'s stock price today?
The current price of BOM:541299 is ₹21.00. The 52 week high of BOM:541299 is ₹32.70 and 52 week low is ₹15.68.
When is next earnings date of Dr Lalchandani Labs Ltd(BOM:541299)?
The next earnings date of Dr Lalchandani Labs Ltd(BOM:541299) is .
Does Dr Lalchandani Labs Ltd(BOM:541299) pay dividends? If so, how much?
Dr Lalchandani Labs Ltd(BOM:541299) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers